Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages

European Journal of Clinical Investigation

Volumn 41, Issue 10, 2011, Pages 1098-1104

  Dahl, Tuva ^a   Ranheim, Trine ^a   Holm, Sverre ^a   Berge, Rolf ^b,c   Aukrust, Pål ^a   Halvorsen, Bente ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atherosclerosis; Foam cell formation; Inflammation; Lipids; Macrophages; Nicotinamide phosphoribosyltransferase

Indexed keywords

ADIPOPHILIN; FAT DROPLET; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LOW DENSITY LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHORBOL MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING KINETICS; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; LIPID OXIDATION; LIPID STORAGE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATION-REDUCTION; REAL-TIME POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 80052623215     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02515.x     Document Type: Article

References (24)

1. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001;104:503-16.
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
3. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn G et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008;51:1258-65.
4. Bjornheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999;19:870-6.
5. Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM et al. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 2006;26:1871-6.
6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30.
7. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14:1431-7.
8. Wang T, Zhang X, Bheda P, Revollo JR, Imai S, Wolberger C. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol 2006;13:661-2.
9. Garten A, Petzold S, Korner A, Imai SI, Kiess W. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 2008;20:130-8.
10. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007;115:972-80.
11. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007;178:1748-58.
12. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 2007;56:2829-39.
13. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004;113:1318-27.
14. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002;32:3225-34.
15. Halvorsen B, Aas UK, Kulseth MA, Drevon CA, Christiansen EN, Kolset SO Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins. Biochem J 1998;331 (Pt 3):743-52.
16. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
17. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing 1. Science 2001;292:464-8.
18. Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 2003;63:7436-42.
19. Skokowa J, Lan D, Thakur BK, Wang F, Gupta K, Cario G et al. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat Med 2009;15:151-8.
20. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008;13:453-61.
21. Stoger JL, Goossens P, de Winther MP. Macrophage heterogeneity: relevance and functional implications in atherosclerosis. Curr Vasc Pharmacol 2010;8:233-48.
22. Ribatti D, Levi-Schaffer F, Kovanen PT. Inflammatory angiogenesis in atherogenesis - a double-edged sword. Ann Med 2008;40:606-21.
23. Ben-Shoshan J, Afek A, Maysel-Auslender S, Barzelay A, Rubinstein A, Keren G et al. HIF-1alpha overexpression and experimental murine atherosclerosis 1. Arterioscler Thromb Vasc Biol 2009;29:665-70.
24. Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo CW et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem 2008;283:34833-43.